Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Albendazole is the usual drug for toxocariasis, but organ and eye forms are treated differently. Here is why steroids matter in the eye and how blood tests guide diagnosis.
Hydroxychloroquine can lower blood glucose by slowing insulin breakdown and improving insulin sensitivity. Here is what that means for people on insulin or sulfonylureas.
One 200 mg dose of doxycycline can lower Lyme risk after a high-risk tick bite, but only under specific conditions. It is not a treatment for an established rash.
Topical 0.5% ivermectin clears most head lice in one 10-minute application without nit combing. Oral ivermectin beat malathion in a major trial but is off-label and limited to children 15 kg or more.
Praziquantel reliably treats Clonorchis and Opisthorchis, flukes linked to bile duct cancer. Fasciola is the exception, and treating it requires triclabendazole.
Weekly azithromycin cut disseminated MAC sharply in advanced HIV. Effective antiretroviral therapy has since made routine prophylaxis unnecessary for most patients.
Randomized trials show that methotrexate, sulfasalazine and hydroxychloroquine together often rival a biologic add-on. Here is the evidence, its limits and the trade-offs.
Why WHO stopped excluding pregnant women from schistosomiasis treatment, and what a randomised trial in Leyte, Philippines found about safety for mothers and babies.
Trials showed doxycycline cures rectal chlamydia more reliably than single-dose azithromycin. This is the evidence behind the 2021 CDC change and where azithromycin still fits.